Furthermore, treatment of murine lymphoma model with anti-4-1BB protein showed tumor rejection due to an increased cytotoxicity response of CD8+ T cells by the augmentation of perforin-granzyme and FasL mechanisms [31]. This evidence concerns the gene CD8A and lymphoma.